Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Ritlecitinib works well and is safe for treating alopecia areata.

Abrocitinib may effectively treat Lichen Planopilaris.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Baricitinib is an effective treatment for severe alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Oral isotretinoin effectively stabilizes frontal fibrosing alopecia.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Ruxolitinib can help regrow hair in severe alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Finasteride reduces AML cell growth by inhibiting androgen receptors.